CAS 1131626-46-4

Gamitrinib TPP

CAS: 1131626-46-4

Gamitrinib TPP targets mitochondrial HSP90, inhibiting cancer, and blocks mitochondrial matrix.

Fórmula: C₅₂H₆₅N₃O₈P

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 891.078

Ref: TM-T11355

Gamitrinib

CAS: 1131626-46-4

Gamitrinib is a small molecule that inhibits polymerase chain reaction (PCR) and transcription-quantitative polymerase chain reaction (RT-qPCR). Gamitrinib binds to the polymerase enzyme, blocking DNA replication. It also has anti-tumor effects, inhibiting the growth of skin cancer cells. Gamitrinib blocks mitochondrial functions by binding to the mitochondrial DNA. This drug also has synergistic effects with other cancer drugs, such as temozolomide. Gamitrinib is a competitive inhibitor of ryanodine receptor and blocks mitochondrial membrane potential, leading to cell death.

Fórmula: C₅₂H₆₅N₃O₈P

Pureza: Min. 95%

Peso molecular: 891.1 g/mol

Ref: 3D-GVB62646